Updates
News & Resources
News & Press Releases
3PBIOVIAN expands its mammalian capacity with a second 2,000 L bioreactor
3PBIOVIAN Strengthens its Sterility Testing Capabilities
Antti Nieminen Renews Board Position at Finnish Bioindustries FIB
3PBIOVIAN and INC partner to expand access to oncology treatments in Colombia through biosimilar development
Resources
How to Prevail Over Common Bottlenecks in Recombinant Protein Development
The European CDMO Model, Powering Biologics Innovation
From Concept To Commercial Reality: Successful Upscaling Strategies For Viral Vector Manufacturing
Process development, scale-up and challenges of TM adenovirus GMP process in the iCELLis
Would you like to start a career with a world leading CDMO? We prioritize our employees as the most important asset of our company.
We are a dedicated team of professionals from over 20 countries, working together in a rich, diverse and multicultural environment to deliver tomorrow’s life-transforming therapies.